These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22396142)

  • 1. Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.
    Wang M; Xie R; Liu R; Jia X; Bao Y; Liu X
    Endocrine; 2012 Oct; 42(2):329-34. PubMed ID: 22396142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
    Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
    Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted proteomics of isolated glomeruli from the kidneys of diabetic rats: sorbin and SH3 domain containing 2 is a novel protein associated with diabetic nephropathy.
    Nakatani S; Kakehashi A; Ishimura E; Yamano S; Mori K; Wei M; Inaba M; Wanibuchi H
    Exp Diabetes Res; 2011; 2011():979354. PubMed ID: 22007191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human nephrin mRNA in diabetic nephropathy.
    Toyoda M; Suzuki D; Umezono T; Uehara G; Maruyama M; Honma M; Sakai T; Sakai H
    Nephrol Dial Transplant; 2004 Feb; 19(2):380-5. PubMed ID: 14736962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy.
    Najafian B; Kim Y; Crosson JT; Mauer M
    J Am Soc Nephrol; 2003 Apr; 14(4):908-17. PubMed ID: 12660325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.
    Zheng JM; Yao GH; Cheng Z; Wang R; Liu ZH
    Diabetologia; 2012 Mar; 55(3):801-11. PubMed ID: 22130579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose Induces IL-1α-Dependent Inflammation and Extracellular Matrix Proteins Expression and Deposition in Renal Tubular Epithelial Cells in Diabetic Kidney Disease.
    Salti T; Khazim K; Haddad R; Campisi-Pinto S; Bar-Sela G; Cohen I
    Front Immunol; 2020; 11():1270. PubMed ID: 32733443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction.
    Gerritsen KG; Leeuwis JW; Koeners MP; Bakker SJ; van Oeveren W; Aten J; Tarnow L; Rossing P; Wetzels JF; Joles JA; Kok RJ; Goldschmeding R; Nguyen TQ
    J Diabetes Res; 2015; 2015():539787. PubMed ID: 26171399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vegfa protects the glomerular microvasculature in diabetes.
    Sivaskandarajah GA; Jeansson M; Maezawa Y; Eremina V; Baelde HJ; Quaggin SE
    Diabetes; 2012 Nov; 61(11):2958-66. PubMed ID: 23093658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.
    Baelde HJ; Eikmans M; Doran PP; Lappin DW; de Heer E; Bruijn JA
    Am J Kidney Dis; 2004 Apr; 43(4):636-50. PubMed ID: 15042541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria.
    Verzola D; Cappuccino L; D'Amato E; Villaggio B; Gianiorio F; Mij M; Simonato A; Viazzi F; Salvidio G; Garibotto G
    Kidney Int; 2014 Dec; 86(6):1229-43. PubMed ID: 24786705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.
    Thomsen LH; Fog-Tonnesen M; Nielsen Fink L; Norlin J; García de Vinuesa A; Hansen TK; de Heer E; Ten Dijke P; Rosendahl A
    Ren Fail; 2017 Nov; 39(1):629-642. PubMed ID: 28805484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
    Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
    J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
    Mezzano S; Aros C; Droguett A; Burgos ME; Ardiles L; Flores C; Schneider H; Ruiz-Ortega M; Egido J
    Nephrol Dial Transplant; 2004 Oct; 19(10):2505-12. PubMed ID: 15280531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.
    Habibi J; Aroor AR; Das NA; Manrique-Acevedo CM; Johnson MS; Hayden MR; Nistala R; Wiedmeyer C; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2019 Mar; 18(1):40. PubMed ID: 30909895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease.
    Liang X; Wang P; Chen B; Ge Y; Gong AY; Flickinger B; Malhotra DK; Wang LJ; Dworkin LD; Liu Z; Gong R
    Kidney Int; 2020 Jan; 97(1):175-192. PubMed ID: 31791666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.